Jeff Banas, OD
Optometrist · Mount Pleasant, WINPI 1619328606
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.0%. 2025 is the largest year on record at $26,221, more than ten times the $399 reported in 2019. Among optometrist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 304 payments — averaging $152.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$10K
- Nordic Pharma, Inc.$7K
- Alcon$7K
- Glaukos Corporation$6K
- Carl Zeiss Meditec USA, Inc.$3K
- Rxsight Inc$2K
- plus $11K from 22 others
What the payments were for
- Consulting fees$20,23944%
- Speaking & faculty fees$9,62621%
- Travel & lodging$5,06411%
- Food & beverage$11,44825%
- Education$1110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 48 | $10,230 |
| Nordic Pharma, Inc. | 2 | $7,334 |
| Alcon | 17 | $6,950 |
| Glaukos Corporation | 12 | $6,175 |
| Carl Zeiss Meditec USA, Inc. | 3 | $2,528 |
| Rxsight Inc | 15 | $2,400 |
| AbbVie(2 entities) | 37 | $2,366 |
| Tarsus Pharmaceuticals, Inc. | 13 | $1,486 |
| Alcon Research LLC | 3 | $1,349 |
| Dompe US, Inc. | 25 | $1,138 |
| Carl Zeiss Meditec, Inc. | 4 | $893 |
| Harrow Eye, LLC | 20 | $627 |
| Novartis | 37 | $598 |
| NEW World Medical,inc. | 7 | $453 |
| Amgen(2 entities) | 12 | $373 |
| Sun Pharmaceutical Industries Inc. | 10 | $369 |
| Oyster Point Pharma, Inc. | 9 | $312 |
| Biotissue Holdings Inc. | 6 | $242 |
| Astellas Pharma US Inc | 4 | $224 |
| Johnson & Johnson Vision Care, Inc. | 1 | $83 |
| Tearlab Corp | 2 | $73 |
| Sight Sciences, Inc. | 3 | $61 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 4 | $60 |
| Kala Pharmaceuticals, Inc. | 3 | $53 |
| Thea Pharma Inc. | 2 | $35 |
| Aerie Pharmaceuticals, Inc. | 2 | $31 |
| Eyevance Pharmaceuticals LLC | 2 | $27 |
| Coopervision Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYZULTA$7,598
- Lacrifill$7,334
- Travoprost Intraocular Implant - iDose$5,108
- Rhopressa$4,247
- VisuMax$3,311
- Rocklatan$2,985
- Hydrus Microstent$2,654
- RXSIGHT INJECTOR HANDPIECE$2,054
- RXSIGHT CONTACT LENS$2,054
- RXSIGHT INJECTOR CARTRIDGE$2,054
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$2,054
- LIGHT ADJUSTABLE LENS (LAL)$1,936
- enVista Aspire IOL$1,045
- TENEO$1,045
- STELLARIS ELITE$1,045
- iDoseTR$601
- MIEBO$502
- XIIDRA$502
- TRYPTYR$500
- Kahook Dual Blade$343
How this compares
$46,487 in reported general payments places this provider in the 95th percentile of 867 optometrist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 216 | $210,829 |
| LumiganBimatoprost | 169 | $71,299 |
| Cyclosporine | 74 | $52,418 |
| XiidraLifitegrast | 40 | $41,367 |
| CombiganBrimonidine Tartrate/Timolol | 113 | $37,748 |
| VyzultaLatanoprostene Bunod | 85 | $37,378 |
| RocklatanNetarsudil Mesylat/Latanoprost | 78 | $29,194 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 110 | $27,199 |
| XdemvyLotilaner | 12 | $24,184 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 143 | $18,370 |
| CequaCyclosporine | 20 | $17,475 |
| TyrvayaVarenicline Tartrate | 20 | $15,371 |
| ProlensaBromfenac Sodium | 38 | $13,521 |
| IlevroNepafenac | 34 | $13,097 |
| RhopressaNetarsudil Mesylate | 18 | $10,977 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Restasis Multidose | $2,366 | $328,444513 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $10,230 | $78,745125 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $31 | $40,17196 claims |
| AlconSimbrinza | $6,950 | $27,199110 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $1,486 | $24,18412 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Lotemax Sm | $60 | $18,80059 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $369 | $17,47520 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $312 | $15,37120 claims |
| NovartisIlevro | $598 | $13,09734 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 867 optometrist providers in Wisconsin.
Other optometrist in Mount Pleasant
- David NelsonMadison$256K
- Jennifer FrieheMukwonago$234K
- Tessa SokolMadison$105K
- Christopher LopezClintonville$48K
- Jessica SchiffbauerKenosha$27K
- Jeffrey ClementsSun Prairie$16K
- Douglas HinsonSturtevant$15K
- Marcus NeitzkeWaukesha$14K
- Michelle KwonHartford$12K
- Amber DentzHartland$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.